Browsing Tag
Boston Pharmaceuticals
1 post
GSK to acquire efimosfermin from Boston Pharmaceuticals for $2bn to bolster liver disease pipeline
GSK acquires Phase III-ready efimosfermin from Boston Pharmaceuticals for $2B, expanding its liver disease pipeline with a fibrosis-reversing specialty drug.